Structure Therapeutics
Piedmont, Italy
Structure Therapeutics develops life‐changing medicines for patients using advanced structure‐based and computational drug discovery technology. The company’s platform combines the latest advancements in visualization of molecular interactions, computational chemistry, and data integration to design orally available, superior small molecule medicines that overcome current limitations of biologic and peptide drugs. We are advancing a clinical‐stage pipeline of differentiated treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic, and pulmonary conditions.
Structure Therapeutics is led by an experienced group of international drug innovators and financed by top-tier global life sciences investors. The company has completed an initial public offering (IPO) in February of 2023. With offices in California and Shanghai, Structure Therapeutics has the benefit of being at the center of life science innovation in both the US and China and capitalizing on the strengths of each geographic location.#LIRemote.
POSITION SUMMARY
The Senior Director, Pharmacometrics will work with cross functional stakeholders across Structure Therapeutics, supporting discovery, preclinical development, and clinical development of pipeline molecules. The position will contribute to translational approaches to streamline clinical development and define the optimal dose, route, and regimen. Additionally, the position will be accountable for the Pharmacometrics aspects of regulatory filings along with presentation of results and key messages to internal teams, executive management, health authorities and external collaborators. The position will report to the VP, Clinical Pharmacology and Pharmacometrics.
ESSENTIAL DUTIES AND RESPONSIBILITIES
CORE COMPETENCIES, KNOWLEDGE, AND SKILL REQUIREMENTS
REQUIREMENTS
Education
Experience
10+ years of drug development experience in the biotech/pharma industry
Experience with dataset creation
Application of pharmacokinetic and pharmacodynamic principles and commonly applied pharmacometric techniques (e.g. PopPK, PKPD, MBMA, statistical modeling), including the use of software’s such as NONMEM, R, Monolix, SAS, Matlab and Phoenix/Winonlin
Pharmacometrics leadership experience representing the function in scientific team settings.
Experience with pharmacometrics aspects related to the development of small molecules.
Experience with regulatory filings (IND, NDA/BLA, MAA)
Scientific excellence as demonstrated through track record of publications or presentations on pharmacometrics applied to drug development
Experience with cardiopulmonary, type 2 diabetes mellitus and obesity preferred.
Experience with PBPK and software’s such as Simcyp and GastroPlus preferred.
Travel
Around 15% for conferences, with a potential to travel to office in China and one week a month to the SSF, CA office.
The target salary range for this full-time role is $246,000 - $295,000 + bonus + equity + benefits. Structure Therapeutics determines salary ranges based on level and scope of responsibilities, as well as location. Individual pay is further determined by additional factors, including relevant experience, specific job skills, education and training. More details about the specific salary range for your location will be discussed with you during the hiring process by the StructureTx Talent Acquisition Team.
This job is not in any teams
This job is not in any offices
Structure Therapeutics
Structure Therapeutics creates life-changing medicines for patients using advanced computational and structure-based technology. Our platform combines the latest advancements in computational chemistry, visualization of molecular interactions, and data integration to design orally available, superior medicines that overcome current limitations inbiologic and peptide drugs. We are advancing our clinical-stage pipeline of differentiated, efficacious and safe treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic and pulmonary conditions. At Structure, our team’s deep experience with complex biological targets and mechanisms, structure-based drug design, and global drug discovery and development enables our bold vision: to design and develop world-class medicines with tremendous patient impact and broad commercial opportunity.